Last, I would consider an iodine or iron deficiency, as these
could easily explain chronic fatigue, and are easily addressed. <<

OF .. all the diseases which INDUCE .. anemia .. IE: iron withholding
mechanism .. which is .. **every** disease / 2700 or so .. YOU .. find
iron **deficiency** .. would be "right up there with the premiere
CAUSE of your .. tiredness .. " ..

???

This is a full grown .. man ..

YOU .. "believe" .. iron **defciency** would / could .. BE .. this
man's .. problem .. ?

Explain that ..

Explain what .. criteria .. you .. used .. TO .. discern that iron
deficiency "might" .. BE .. **remotely** .. involved .. even a ..
chance of BEING involved ..

Blood in the urine .. ? .. blood in his crap .. ?

Men bleed at such a high rate he would be .. iron deficient .. ?

Age related iron accumulation leads to .. evidence of YOUR .. b-a-d ..
advice ..

You are sending him down a path which .. statistically .. / odds ..
are .. would be a .. long shot .. bet ..

IMHO ..

<<snip>>
Iron accumulation in tissues is believed to be a characteristic of
aged humans
<<snip>>.

Age-associated Iron Accumulation in Bone: Implications for
Postmenopausal Osteoporosis and a New Target for Prevention and
Treatment by Chelation.
Liu G, Men P, Kenner GH, Miller SC
Biometals. 2006 May 11;

Iron accumulation in tissues is believed to be a characteristic of
aged
humans and a risk factor for some chronic diseases. However, it is
not
known whether age-associated iron accumulation is part of the
pathogenesis of postmenopausal osteoporosis that affects
approximately
one out three women worldwide. Here, we confirmed that this
accumulation of iron was associated with osteopenia in ovariectomized
(OVX) rats (a model of peri- and postmenopausal osteoporosis due to
estrogen deficiency). To further investigate whether the increased
iron

level plays a causal role in the onset of bone loss, we treated OVX
rats with an orally active and bone targeted chelator that prevented
iron accumulation in their skeletal tissues. The results showed that
this treatment mitigated the loss of bone mass and the deterioration
of

bone micro-architecture. We also found that one possible mechanism of
the protective action of iron chelation was to significantly reduce
bone resorption. Thus, these findings provide a novel target and a
potentially useful therapeutic strategy for the prevention and
treatment of postmenopausal osteoporosis and perhaps other age-
related
diseases.
---------------------------------------------------------------------------­---------------------------

Iron-controlling Molecule in Soy, Not Plant Estrogens, Found to Reduce
Cardiovascular Disease Risks; Throws Cholesterol Theory of Heart
Disease Out the Window

Researchers find age-related iron accumulation raises risk markers for
cardiovascular disease. Risk factors can be reversed with rice bran
molecule, as an alternative to soy.

San Dimas, CA (PRWEB) December 18, 2006 -- Researchers have now shown
that an iron-controlling molecule in soy protein, and not the widely
touted phyto (plant) estrogens, is responsible for reductions in
cardiovascular disease risks. Phytoestrogens in soy protein had no
effect on cardiovascular disease risk markers such as homocysteine, C-
reactive protein or iron accumulation.

The Food & Drug Administration approved health claims for soy protein
in 1999 as a food that reduces the risk for heart disease. But the
ingredients in soy that produce this health benefit were not
identified at the time.

American medicine appears to be on the wrong road in preventing heart
disease
The research study, published in the October 2006 issue of the
American Journal of Clinical Nutrition, and conducted by researchers
at Iowa State University, suggests iron accumulation is a more
important factor than cholesterol in predicting future heart attacks
and strokes, says Bill Sardi, president of Knowledge of Health, Inc,
San Dimas, California. "In fact, C-reactive protein is considered to
be a better predictor of future heart attacks than cholesterol," says
Sardi.

Researchers gave postmenopausal women high and low amounts of soy
isoflavones, the weak estrogen-like molecules found in soy, and high
(650-780 mg) and low (220 mg) amounts of IP6 phytate, an iron-
controlling molecule, in a 40-gram daily soy protein supplement. Only
the IP6 phytate significantly lowered iron, homocysteine and C-
reactive protein levels, which are markers for cardiovascular disease,
says Sardi.

The IP6 phytate from soy is also found in the bran portion of whole
grains. IP6 phytate has been mischaracterized as an "anti-nutrient"
says Sardi, because it may reduce iron levels in growing children and
fertile women who both tend to be anemic. But in full-grown males and
postmenopausal females who are prone to iron overload, IP6 phytate may
be the key dietary molecule that controls cardiovascular risks.

"Once women begin to lose control of iron by cessation of menstruation
either via menopause or early hysterectomy, they will begin to
accumulate iron as adult males do. Males begin accumulating iron after
full growth is achieved, around age 18, and by age 40 have double the
iron load as an equal-aged female and twice the rate of heart
disease," says Sardi.

"American medicine appears to be on the wrong road in preventing heart
disease," says Sardi, noting that cholesterol reduction has not dented
cardiovascular mortality rates significantly. About the same number of
Americans succumb to mortal heart attacks each year, despite
widespread programs to reduce cholesterol by diet or medication, he
notes.

Postmenopausal women, whose iron levels are relatively high, are 3.4
times more at risk for cardiovascular disease than premenopausal
women, whose iron levels are lower.

Consumers can also acquire phytate IP6 as an extract of rice bran as a
dietary supplement (produced by Tsuno Foods of Wakayama, Japan
( www.tsuno.co.jp ), for brands like Source Naturals, Jarrow Formulas
and Purity Products). Many whole grains have been engineered to reduce
bran/IP6 factors in order to minimize anemia in young children and
fertile females, but this removes the protective iron-controlling
factor for full-grown males and postmenopausal females. For adults who
wish to avoid soy or are allergic to soy products, supplementation
with oral phytate IP6 rice bran extract in the range of 800-2000 mg
per day may be beneficial for full-grown males and postmenopausal
females.

Bill Sardi is author of the ebook, The Iron Time Bomb
( www.naturalhealthlibrarian.com )

Reference: Hanson LN, Engelman HM, Alekel DL, et al (Dept. Food
Science and Human Nutrition, Iowa State University, Ames, Iowa),
Effects of soy isoflavones and phytate on homocysteine, C-reactive
protein, and iron status in postmenopausal women. American Journal
Clinical Nutrition 84: 774-80, 2006.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/TWFnbi1Db3VwLUNvdXAtVGhpci1NYWduLVplcm8=

soy rice bran ip6 iron

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com

Man Is A Herbivore!
http://tinyurl.com/a3cc3